Gerhardt Pohl

1.7k total citations
43 papers, 1.3k citations indexed

About

Gerhardt Pohl is a scholar working on Oncology, Economics and Econometrics and Genetics. According to data from OpenAlex, Gerhardt Pohl has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Economics and Econometrics and 7 papers in Genetics. Recurrent topics in Gerhardt Pohl's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Economic and Financial Impacts of Cancer (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Gerhardt Pohl is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Economic and Financial Impacts of Cancer (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Gerhardt Pohl collaborates with scholars based in United States, United Kingdom and Belgium. Gerhardt Pohl's co-authors include Howard G. Birnbaum, Robert Lindsay, Crystal Pike, Ronald B. Natale, Catherine E. Muehlenbein, Barbara Sternfeld, Kraig Kinchen, Nancy H. Fultz, Jean‐Yves Reginster and Wim H. Scheele and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gerhardt Pohl

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerhardt Pohl United States	16	482	330	240	201	193	43	1.3k
Marcy B. Bolster United States	24	185 0.4×	186 0.6×	198 0.8×	457 2.3×	447 2.3×	104	1.9k
Carlen Reyes Spain	18	240 0.5×	292 0.9×	177 0.7×	335 1.7×	49 0.3×	48	1.3k
Mustafa Şenocak Türkiye	17	173 0.4×	119 0.4×	85 0.4×	176 0.9×	113 0.6×	57	1.1k
Stuart Silverman United States	13	268 0.6×	781 2.4×	185 0.8×	86 0.4×	45 0.2×	35	1.3k
Matthias Kalder Germany	25	709 1.5×	227 0.7×	206 0.9×	53 0.3×	180 0.9×	113	1.8k
Lewis H. Kuller United States	18	323 0.7×	68 0.2×	147 0.6×	451 2.2×	151 0.8×	25	2.0k
Francisco Bandeira Brazil	28	987 2.0×	1.0k 3.1×	458 1.9×	133 0.7×	240 1.2×	125	3.1k
Douglas K. Heilman United States	20	300 0.6×	104 0.3×	343 1.4×	589 2.9×	421 2.2×	28	1.9k
Thomas V. Paul India	23	182 0.4×	351 1.1×	217 0.9×	53 0.3×	127 0.7×	166	1.6k
W. Michael O'Fallon United States	10	181 0.4×	398 1.2×	129 0.5×	130 0.6×	52 0.3×	10	955

Countries citing papers authored by Gerhardt Pohl

Since Specialization

Citations

This map shows the geographic impact of Gerhardt Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhardt Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhardt Pohl more than expected).

Fields of papers citing papers by Gerhardt Pohl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhardt Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhardt Pohl. The network helps show where Gerhardt Pohl may publish in the future.

Co-authorship network of co-authors of Gerhardt Pohl

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhardt Pohl. A scholar is included among the top collaborators of Gerhardt Pohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhardt Pohl. Gerhardt Pohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doty, Erin, John H. Krege, Gerhardt Pohl, et al.. (2020). Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant. Headache The Journal of Head and Face Pain. 60(8). 1793–1796. 6 indexed citations

Gilden, Daniel, Joanna Kubisiak, Gerhardt Pohl, et al.. (2016). Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients. Journal of Medical Economics. 20(2). 151–161. 13 indexed citations

Karve, Sudeep, Gregory L. Price, Keith L. Davis, et al.. (2014). Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers. BMC Health Services Research. 14(1). 555–555. 28 indexed citations

Pennella, Eduardo J., Coleman K. Obasaju, Gerhardt Pohl, et al.. (2013). Prospective Observational Comparison of Clinical Outcomes Between African-American and Caucasian Patients Receiving Second-Line Treatment With Pemetrexed for Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 14(6). 726–735. 5 indexed citations

Karve, Sudeep, Gregory L. Price, Keith L. Davis, Gerhardt Pohl, & Emily Nash Smyth. (2012). Comparison of treatment patterns, health care utilization, and direct costs in elderly patients with distant-stage small cell lung cancer (SCLC) versus non-small cell lung cancer (NSCLC) using the SEER-Medicare database.. Journal of Clinical Oncology. 30(15_suppl). 7101–7101. 1 indexed citations

Muehlenbein, Catherine E., et al.. (2011). Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 2011. 1–5. 6 indexed citations

Colosia, Ann, Gerson Peltz, Gerhardt Pohl, et al.. (2010). A review and characterization of the various perceptions of quality cancer care. Cancer. 117(5). 884–896. 13 indexed citations

Meadows, Eric S., Stephen S. Johnston, Zhun Cao, et al.. (2010). Illness-Associated Productivity Costs Among Women With Employer-Sponsored Insurance and Newly Diagnosed Breast Cancer. Journal of Occupational and Environmental Medicine. 52(4). 415–420. 15 indexed citations

Foster, Shonda A., et al.. (2010). Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance. Osteoporosis International. 22(2). 551–557. 36 indexed citations

10.

Pohl, Gerhardt, David L. Van Brunt, Wenyu Ye, William W. Stoops, & Joseph A. Johnston. (2009). A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD). BMC Health Services Research. 9(1). 95–95. 29 indexed citations

11.

Foster, Shonda A., et al.. (2007). Characteristics of patients initiating teriparatide for the treatment of osteoporosis. Osteoporosis International. 19(3). 373–377. 14 indexed citations

12.

Yu, Andrew P., Eric Q. Wu, Howard G. Birnbaum, et al.. (2007). Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data. Current Medical Research and Opinion. 23(9). 2157–2169. 60 indexed citations

13.

Johnston, Joseph A., Wenyu Ye, David L. Van Brunt, Gerhardt Pohl, & Calvin R. Sumner. (2006). Decreased Use of Clonidine Following Treatment With Atomoxetine in Children With ADHD. Journal of Clinical Psychopharmacology. 26(4). 389–395. 2 indexed citations

14.

Brunt, David L. Van, et al.. (2006). Factors Associated With Initiation With Atomoxetine Versus Stimulants in the Treatment of Adults With ADHD: Retrospective Analysis of Administrative Claims Data. Journal of Managed Care Pharmacy. 12(3). 230–238. 13 indexed citations

15.

Fultz, Nancy H., et al.. (2005). Prevalence, management and impact of urinary incontinence in the workplace. Occupational Medicine. 55(7). 552–557. 69 indexed citations

16.

Brunt, David L. Van, Joseph A. Johnston, Wenyu Ye, et al.. (2005). Predictors of Selecting Atomoxetine Therapy for Children with Attention‐Deficit—Hyperactivity Disorder. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(11). 1541–1549. 15 indexed citations

17.

Sun, Peter P., Allen D. Seftel, Ralph Swindle, Wenyu Ye, & Gerhardt Pohl. (2005). THE COSTS OF CARING FOR ERECTILE DYSFUNCTION IN A MANAGED CARE SETTING: EVIDENCE FROM A LARGE NATIONAL CLAIMS DATABASE. The Journal of Urology. 174(5). 1948–1952. 18 indexed citations

18.

Lindsay, Robert, Wim H. Scheele, Robert M. Neer, et al.. (2004). Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis. Archives of Internal Medicine. 164(18). 2024–2024. 237 indexed citations

19.

Turner, Ronald B., Margaret Wecker, Gerhardt Pohl, et al.. (1999). Efficacy of Tremacamra, a Soluble Intercellular Adhesion Molecule 1, for Experimental Rhinovirus Infection. JAMA. 281(19). 1797–1797. 140 indexed citations

20.

Pohl, Gerhardt, et al.. (1977). [Concordant medullary thyroid carcinoma in identical twins with discordant phaeochromocytoma (Sipple syndrome) (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 89(14). 481–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact